|
SENP6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.97229999998605E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.236300E-04 |
| Normal-vs-Stage2 |
6.823800E-02 |
| Normal-vs-Stage3 |
3.46610000034886E-07 |
| Normal-vs-Stage4 |
8.05409999804496E-08 |
| Stage1-vs-Stage2 |
9.920200E-01 |
| Stage1-vs-Stage3 |
1.260370E-02 |
| Stage1-vs-Stage4 |
4.175800E-03 |
| Stage2-vs-Stage3 |
2.168400E-01 |
| Stage2-vs-Stage4 |
1.327390E-01 |
| Stage3-vs-Stage4 |
6.070600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64709999994628E-06 |
| Normal-vs-AfricanAmerican |
3.778500E-03 |
| Normal-vs-Asian |
2.784400E-01 |
| Caucasian-vs-AfricanAmerican |
6.595600E-01 |
| Caucasian-vs-Asian |
6.047600E-01 |
| AfricanAmerican-vs-Asian |
7.158800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.23600000012658E-07 |
| Normal-vs-Female |
4.677600E-03 |
| Male-vs-Female |
7.419000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.099170E-03 |
| Normal-vs-Age(41-60Yrs) |
1.182190E-03 |
| Normal-vs-Age(61-80Yrs) |
1.45669999995768E-06 |
| Normal-vs-Age(81-100Yrs) |
3.597300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.511800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.766400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.700000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.006100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.536450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.211000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.229400E-01 |
| Normal-vs-Grade 2 |
1.734460E-02 |
| Normal-vs-Grade 3 |
2.46760001321178E-09 |
| Normal-vs-Grade 4 |
4.44079994998958E-10 |
| Grade 1-vs-Grade 2 |
7.390000E-02 |
| Grade 1-vs-Grade 3 |
2.34289999999637E-05 |
| Grade 1-vs-Grade 4 |
3.65030000004651E-06 |
| Grade 2-vs-Grade 3 |
1.777380E-04 |
| Grade 2-vs-Grade 4 |
2.32810000000416E-06 |
| Grade 3-vs-Grade 4 |
4.239700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.977900E-02 |
| Normal-vs-ccB subtype |
1.05839999986479E-07 |
| ccA subtype-vs-ccB subtype |
2.165400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.230360E-04 |
| Normal-vs-N1 |
6.791900E-04 |
| N0-vs-N1 |
2.085600E-01 |
|
|
